Keywords: Antisense Pharma, Trabedersen, IND, Glioma, FDA
Antisense Pharma obtains IND for clinical studies of trabedersen in the USA
Article | 04 August 2010
German biopharmaceutical company Antisense Pharma says that the US Food and Drug Administration has issued an Investigational New Drug-authorization for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
